BioRestorative Therapies (NASDAQ:BRTX) Shares Up 0.3% – Should You Buy?

BioRestorative Therapies, Inc. (NASDAQ:BRTX)’s stock price shot up 0.3% on Monday . The stock traded as high as $1.84 and last traded at $1.81. 2,203,978 shares traded hands during trading, an increase of 302% from the average session volume of 547,725 shares. The stock had previously closed at $1.81.

BioRestorative Therapies Stock Performance

The firm has a market cap of $13.58 million, a P/E ratio of -1.18 and a beta of 76.75. The company has a 50-day moving average of $1.74 and a 200 day moving average of $1.77.

BioRestorative Therapies (NASDAQ:BRTX) last posted its earnings results on Wednesday, May 14th. The company reported ($0.56) EPS for the quarter, missing the consensus estimate of ($0.32) by ($0.24). BioRestorative Therapies had a negative return on equity of 98.49% and a negative net margin of 2,697.08%. The company had revenue of $0.03 million for the quarter, compared to the consensus estimate of $0.38 million. Sell-side analysts anticipate that BioRestorative Therapies, Inc. will post -1.43 EPS for the current fiscal year.

Hedge Funds Weigh In On BioRestorative Therapies

A hedge fund recently bought a new stake in BioRestorative Therapies stock. Citadel Advisors LLC acquired a new stake in BioRestorative Therapies, Inc. (NASDAQ:BRTX) in the 4th quarter, according to the company in its most recent filing with the SEC. The fund acquired 21,481 shares of the company’s stock, valued at approximately $31,000. Citadel Advisors LLC owned about 0.31% of BioRestorative Therapies as of its most recent filing with the SEC. Hedge funds and other institutional investors own 69.38% of the company’s stock.

About BioRestorative Therapies

BioRestorative Therapies, Inc, a life sciences company, focuses on the development of regenerative medicine products and therapies using cell and tissue protocols primarily involving adult stem cells. The company's two core developmental programs relate to the treatment of disc/spine disease and metabolic disorders.